Aleksandra V. Solov'YEva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aleksandra V. Solov'YEva has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Oleg Mikhaylovich Uryas'Ev
Ryazan State Medical University named after academician I.P. Pavlov
7 shared publications Ryazan State Medical University
4 shared publications- Aleksey V. Cheskidov
Ryazan State Medical University
3 shared publications - Alexandr S. Pristupa
Regional Clinical Hospital; Ryazan State Medical University named after academician I.P. Pavlov
2 shared publications Alexandra V. Solovieva
Ryazan State Medical University
2 shared publications- Elena A. Maksimtseva
Ryazan State Medical University
2 shared publications
Latest Publications
- 30 December 2025
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 33 (4) , 611-620
Thyroid dysfunction in liver pathology
INTRODUCTION: A close functional relationship between the liver and thyroid gland suggests co-dependence of processes occurring in them not only under normal conditions, but also in pathology. The impact of thyroid dysfunction on change in the liver state has been extensively explored in the literature, while the converse — the impact of liver pathology on thyroid functional condition — requires additional analysis and study. AIM: To study changes in the functional condition of the thyroid gland in the most common liver diseases. An information search was conducted in the eLibrary, PubMed databases for the period from January 01, 2004 to April 01, 2004 with no restrictions on the type of publication. The following keywords were used: thyroid dysfunction, thyroxine, triiodothyronine, non-alcoholic fatty liver disease, chronic hepatitis, liver cirrhosis, hemochromatosis, Wilson's disease. An analysis of the literature sources demonstrates various mechanisms of thyroid dysfunction in liver diseases. Non-alcoholic fatty liver disease (NAFLD) is indirectly related to impaired thyroid function and potentiation of metabolic syndrome manifestations through insulin resistance and obesity. Data on thyroid dysfunction in a patient with NAFLD due to the development of autoimmune damage and an increased risk of thyroid cancer also deserve the attention of the clinician. A probability for autoimmune thyroid damage should necessarily be taken into account in patients with autoimmune hepatitis. The incidence of interferon-induced thyroid dysfunction is currently declining due to changes in the antiviral therapy protocols. Literature data indicate an increased risk of thyroid cancer in infection with hepatitis C virus. Data on the impact of liver cirrhosis on thyroid function are contradictory, most commonly noted are reduction of triiodothyronine and thyroxine levels due to the involvement of liver in thyroid homeostasis (liver deiodinase system, thyroxine-binding globulin). Iron overload of thyrocytes in hemochromatosis can in some cases be accompanied by changes in thyroid status. CONCLUSION: Thus, further investigation of thyroid status in liver diseases is needed, on the one hand, to elucidate mechanisms of thyroid dysfunction, and on the other, to determine a probable role of triiodothyronine and thyroxine levels as markers of severity of liver dysfunction. The data accumulated to date allow us to recommend studying thyroid hormonal status in chronic liver diseases.
- 30 December 2025
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 33 (4) , 611-620
Thyroid dysfunction in liver pathology
INTRODUCTION: A close functional relationship between the liver and thyroid gland suggests co-dependence of processes occurring in them not only under normal conditions, but also in pathology. The impact of thyroid dysfunction on change in the liver state has been extensively explored in the literature, while the converse — the impact of liver pathology on thyroid functional condition — requires additional analysis and study. AIM: To study changes in the functional condition of the thyroid gland in the most common liver diseases. An information search was conducted in the eLibrary, PubMed databases for the period from January 01, 2004 to April 01, 2004 with no restrictions on the type of publication. The following keywords were used: thyroid dysfunction, thyroxine, triiodothyronine, non-alcoholic fatty liver disease, chronic hepatitis, liver cirrhosis, hemochromatosis, Wilson's disease. An analysis of the literature sources demonstrates various mechanisms of thyroid dysfunction in liver diseases. Non-alcoholic fatty liver disease (NAFLD) is indirectly related to impaired thyroid function and potentiation of metabolic syndrome manifestations through insulin resistance and obesity. Data on thyroid dysfunction in a patient with NAFLD due to the development of autoimmune damage and an increased risk of thyroid cancer also deserve the attention of the clinician. A probability for autoimmune thyroid damage should necessarily be taken into account in patients with autoimmune hepatitis. The incidence of interferon-induced thyroid dysfunction is currently declining due to changes in the antiviral therapy protocols. Literature data indicate an increased risk of thyroid cancer in infection with hepatitis C virus. Data on the impact of liver cirrhosis on thyroid function are contradictory, most commonly noted are reduction of triiodothyronine and thyroxine levels due to the involvement of liver in thyroid homeostasis (liver deiodinase system, thyroxine-binding globulin). Iron overload of thyrocytes in hemochromatosis can in some cases be accompanied by changes in thyroid status. CONCLUSION: Thus, further investigation of thyroid status in liver diseases is needed, on the one hand, to elucidate mechanisms of thyroid dysfunction, and on the other, to determine a probable role of triiodothyronine and thyroxine levels as markers of severity of liver dysfunction. The data accumulated to date allow us to recommend studying thyroid hormonal status in chronic liver diseases.
- 30 September 2025
- Published by Ryazan State Medical University in Nauka Molodykh (Eruditio Juvenium)
- Vol. 13 (3)
Systemic Thrombolytic Therapy for Ischemic Stroke: Experience of the Regional Vascular Center
INTRODUCTION: Systemic thrombolysis is an effective and safe method of reperfusion therapy in ischemic stroke. However, the effectiveness and safety of different thrombolytic drugs are not the same. It is relevant to analyze the use of systemic thrombolytics in real clinical practice of the Regional Vascular Center. AIM: To compare the effectiveness and safety of thrombolytic therapy (TLT) with non-immunogenic staphylokinase (forteplase) and tissue plasminogen activator (alteplase) in patients with acute ischemic stroke hospitalized in the Regional Vascular Center. MATERIALS AND METHODS: A retrospective analysis of medical histories of 60 patients of the Regional Vascular Center was conducted. Group 1 (33 patients) received non-immunogenic staphylokinase, group 2 (27 patients) — alteplase. The groups had no statistically significant differences except for a higher incidence of diabetes in group 1. Before TLT and on day 1 after, neurologic deficit was evaluated on NIHSS scale, and clinical outcomes on the modified Rankin scale; evaluation on rehabilitation routing scale (RRS) was conducted on day 10. Safety of systemic thrombolysis was assessed by the existence of hemorrhagic complications, the development of a fatal outcome. RESULTS: In group 1 a statistically significant positive dynamics was obtained on day 1 on NIHSS, Rankin scale and on day 10 on RRS. One case of hemorrhagic transformation with a fatal outcome was recorded. In group 2 no statistically significant dynamics in the above parameters was recorded. Intracerebral hematoma and hemorrhagic transformation in 2 patients (7.4%). Fatal outcome at the hospital stage was statistically significantly more frequent in group 2 — 11 patients (40.7%) versus 6 patients (18.1%). CONCLUSION: The conducted retrospective comparative analysis of TLT in the acute period of ischemic stroke showed a higher effectiveness compared to alteplase, no less safety of non-immunogenic staphylokinase in terms of hemorrhagic complications, and lower mortality in the staphylokinase group in the hospital observation period.
- 30 September 2025
- Published by Ryazan State Medical University in Nauka Molodykh (Eruditio Juvenium)
- Vol. 13 (3)
Systemic Thrombolytic Therapy for Ischemic Stroke: Experience of the Regional Vascular Center
INTRODUCTION: Systemic thrombolysis is an effective and safe method of reperfusion therapy in ischemic stroke. However, the effectiveness and safety of different thrombolytic drugs are not the same. It is relevant to analyze the use of systemic thrombolytics in real clinical practice of the Regional Vascular Center. AIM: To compare the effectiveness and safety of thrombolytic therapy (TLT) with non-immunogenic staphylokinase (forteplase) and tissue plasminogen activator (alteplase) in patients with acute ischemic stroke hospitalized in the Regional Vascular Center. MATERIALS AND METHODS: A retrospective analysis of medical histories of 60 patients of the Regional Vascular Center was conducted. Group 1 (33 patients) received non-immunogenic staphylokinase, group 2 (27 patients) — alteplase. The groups had no statistically significant differences except for a higher incidence of diabetes in group 1. Before TLT and on day 1 after, neurologic deficit was evaluated on NIHSS scale, and clinical outcomes on the modified Rankin scale; evaluation on rehabilitation routing scale (RRS) was conducted on day 10. Safety of systemic thrombolysis was assessed by the existence of hemorrhagic complications, the development of a fatal outcome. RESULTS: In group 1 a statistically significant positive dynamics was obtained on day 1 on NIHSS, Rankin scale and on day 10 on RRS. One case of hemorrhagic transformation with a fatal outcome was recorded. In group 2 no statistically significant dynamics in the above parameters was recorded. Intracerebral hematoma and hemorrhagic transformation in 2 patients (7.4%). Fatal outcome at the hospital stage was statistically significantly more frequent in group 2 — 11 patients (40.7%) versus 6 patients (18.1%). CONCLUSION: The conducted retrospective comparative analysis of TLT in the acute period of ischemic stroke showed a higher effectiveness compared to alteplase, no less safety of non-immunogenic staphylokinase in terms of hemorrhagic complications, and lower mortality in the staphylokinase group in the hospital observation period.
- Open Access
- 30 September 2025
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 33 (3) , 387-394
Peculiarities of the course of acute coronary syndrome in anemia according to the registry of the Regional Vascular Center of the Ryazan Region
INTRODUCTION: Anemia not only negatively affects the course and prognosis of acute coronary syndrome (ACS), but can also influence the choice of treatment. It seems relevant to study the regional features of the course and prognosis of ACS in combination with anemia. AIM: To study the incidence and severity of anemia in patients with ACS, the features of the course and outcomes of ACS in patients with anemia according to the registry of the Regional Vascular Center of the Ryazan Region. MATERIALS AND METHODS: A retrospective analysis of the ACS registry data for 2019 was performed, which included 242 patients: group 1 — patients with anemia (n = 52; 21.5%), group 2 — patients without anemia (n = 190; 78.5%). All analyzed data were obtained from the medical records of the inpatients. RESULTS: Eighty five percent of patients in group 1 had mild, 11% — moderate, and 4% — severe anemia. Patients with ACS in combination with anemia were older (p = 0.0001). There were more women in the anemia group (p 0.001), these patients more often had a history of myocardial infarction (p 0.001), stroke (p = 0.03), angina (p = 0.009); they had lower blood pressure (p = 0.002 for systolic and p = 0.0004 for diastolic), glomerular filtration rate (p = 0.0005), left ventricular ejection fraction (p = 0.01). Killip class II heart failure was more often recorded in the presence of anemia (p = 0.009), the risk of in-hospital mortality according to the GRACE scale was also higher in patients with anemia (p 0.001). Coronary angiography and percutaneous coronary intervention were more often performed in the group with ACS without anemia (p 0.001 and p = 0.005 respectively). In-hospital mortality in patients with anemia exceeded that in patients without anemia (17.3% versus 7.9%, p = 0.04). Mild anemia was predominant among deceased patients (80.0%). CONCLUSION: According to the ACS registry of the Regional Vascular Center for 2019, anemia was detected in 21.5% of patients, with mild anemia predominating. Patients with ACS and anemia more often had angina pectoris, postinfarction cardiosclerosis and stroke in history, and according to the GRACE scale, a higher risk of hospital mortality. They were less likely to undergo coronary angiography and percutaneous coronary intervention compared to patients with ACS without anemia. Hospital mortality was higher in the ACS group with anemia; among the deceased, mild anemia predominated.
- 30 September 2025
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 33 (3) , 387-394
Open AccessPeculiarities of the course of acute coronary syndrome in anemia according to the registry of the Regional Vascular Center of the Ryazan Region
INTRODUCTION: Anemia not only negatively affects the course and prognosis of acute coronary syndrome (ACS), but can also influence the choice of treatment. It seems relevant to study the regional features of the course and prognosis of ACS in combination with anemia. AIM: To study the incidence and severity of anemia in patients with ACS, the features of the course and outcomes of ACS in patients with anemia according to the registry of the Regional Vascular Center of the Ryazan Region. MATERIALS AND METHODS: A retrospective analysis of the ACS registry data for 2019 was performed, which included 242 patients: group 1 — patients with anemia (n = 52; 21.5%), group 2 — patients without anemia (n = 190; 78.5%). All analyzed data were obtained from the medical records of the inpatients. RESULTS: Eighty five percent of patients in group 1 had mild, 11% — moderate, and 4% — severe anemia. Patients with ACS in combination with anemia were older (p = 0.0001). There were more women in the anemia group (p 0.001), these patients more often had a history of myocardial infarction (p 0.001), stroke (p = 0.03), angina (p = 0.009); they had lower blood pressure (p = 0.002 for systolic and p = 0.0004 for diastolic), glomerular filtration rate (p = 0.0005), left ventricular ejection fraction (p = 0.01). Killip class II heart failure was more often recorded in the presence of anemia (p = 0.009), the risk of in-hospital mortality according to the GRACE scale was also higher in patients with anemia (p 0.001). Coronary angiography and percutaneous coronary intervention were more often performed in the group with ACS without anemia (p 0.001 and p = 0.005 respectively). In-hospital mortality in patients with anemia exceeded that in patients without anemia (17.3% versus 7.9%, p = 0.04). Mild anemia was predominant among deceased patients (80.0%). CONCLUSION: According to the ACS registry of the Regional Vascular Center for 2019, anemia was detected in 21.5% of patients, with mild anemia predominating. Patients with ACS and anemia more often had angina pectoris, postinfarction cardiosclerosis and stroke in history, and according to the GRACE scale, a higher risk of hospital mortality. They were less likely to undergo coronary angiography and percutaneous coronary intervention compared to patients with ACS without anemia. Hospital mortality was higher in the ACS group with anemia; among the deceased, mild anemia predominated.
- 2 July 2025
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 33 (2) , 213-220
Clinical, Morphological and Morphometric Analysis of the Interatrial Septum in Patients with Coronary Heart Disease and Obesity
INTRODUCTION: Obesity is an important factor that facilitates the development of lipomatosis and fibrosis of the interatrial septum (IAS). Currently, non-invasive methods for assessing these pathological conditions are being actively developed. To introduce the developed methods in routine clinical practice, it is necessary to confirm the comparability of their results with the results of morphological studies. AIM: To conduct clinical, morphological and morphometric analysis of the IAS in patients with coronary heart disease (CHD) and obesity. MATERIALS AND METHODS: The study included 116 patients with the diagnosis of CHD, who underwent anthropometric measurements and echocardiography (EchoCG). Morphological and morphometric examinations were conducted on the material taken on autopsy from 74 patients with the main diagnosis of CHD. All patients were diagnosed with arterial hypertension. RESULTS: Based on body mass index, patients with degree 1 obesity predominated. Based on EchoCG results, thickness of IAS in the group of patients with abdominal obesity was greater than in the group of patients without abdominal obesity. In morphometric examination, the percentage of adipose tissue in the IAS was higher in the group of patients with obesity than in the group without obesity. CONCLUSIONS: The thickness of IAS is associated with increased parameters of waist circumference, body mass index and epicardial fat, based on the results of EchoCG. In the morphological examination, an increase in the thickness of epicardial fat and IAS was recorded in patients with obesity. Based on the morphometry data, the percentage of adipose tissue in histological samples of IAS was statistically higher in the group of patients with CHD and abdominal obesity than in patients without obesity (p=0.0002).
- 2 July 2025
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 33 (2) , 213-220
Clinical, Morphological and Morphometric Analysis of the Interatrial Septum in Patients with Coronary Heart Disease and Obesity
INTRODUCTION: Obesity is an important factor that facilitates the development of lipomatosis and fibrosis of the interatrial septum (IAS). Currently, non-invasive methods for assessing these pathological conditions are being actively developed. To introduce the developed methods in routine clinical practice, it is necessary to confirm the comparability of their results with the results of morphological studies. AIM: To conduct clinical, morphological and morphometric analysis of the IAS in patients with coronary heart disease (CHD) and obesity. MATERIALS AND METHODS: The study included 116 patients with the diagnosis of CHD, who underwent anthropometric measurements and echocardiography (EchoCG). Morphological and morphometric examinations were conducted on the material taken on autopsy from 74 patients with the main diagnosis of CHD. All patients were diagnosed with arterial hypertension. RESULTS: Based on body mass index, patients with degree 1 obesity predominated. Based on EchoCG results, thickness of IAS in the group of patients with abdominal obesity was greater than in the group of patients without abdominal obesity. In morphometric examination, the percentage of adipose tissue in the IAS was higher in the group of patients with obesity than in the group without obesity. CONCLUSIONS: The thickness of IAS is associated with increased parameters of waist circumference, body mass index and epicardial fat, based on the results of EchoCG. In the morphological examination, an increase in the thickness of epicardial fat and IAS was recorded in patients with obesity. Based on the morphometry data, the percentage of adipose tissue in histological samples of IAS was statistically higher in the group of patients with CHD and abdominal obesity than in patients without obesity (p=0.0002).
- Open Access
- 16 June 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
Risk factors associated with mortality in patients with multiple myeloma
Introduction. According to foreign authors some laboratory markers and comorbidity are independent predictors of death in multiple myeloma (MM).Aim. To identify risk factors associated with mortality in patients with MM.Materials and methods. A retrospective analysis of 149 medical records of patients of the hematology department of the Regional Clinical Hospital with a diagnosis of multiple myeloma was carried out. The patients are divided into two groups depending on the clinical outcome: the 1st group includes 90 living patients; the 2nd group includes 59 patients whose death occurred in the hospital during the period from 2010–2019. Of the 149 patients: 87 women (58%), 62 men (42%). The mean age of the patients was 65.7 ± 8.7 years. The clinical, demographic and laboratory indicators of the groups were analyzed, and comorbidity was assessed using the Charlson index.Results. In the 1st group of patients, there were 35 men (39%) and 55 women (61%). The ratio of men to women is 1:1.6. The mean age in this group is 67 ± 9.1 years. The 2nd group is represented by 27 (46%) men, 32 (54%) women. The mean age was 63.7 ± 7.6 years. In the 1st group of patients, all patients were diagnosed with stage III disease, with most patients in the subgroup associated with renal dysfunction (p = 0.002). Anaemia and markers of renal damage were more frequent in the group of deceased patients (p < 0.001, p = 0.002, respectively). Comparative analysis of laboratory indicators showed that in the haemogram of the group of living patients, the level of erythrocytes, haemoglobin, platelets was significantly higher than in group 2 (p < 0.05); the level of creatinine, urea was 1.8 times higher in the group of deceased patients than in the group of living patients (p < 0.05). Chronic heart failure was statistically significantly more common in the deceased group than in the living group (22% vs. 7.8%, p = 0.025). The incidence of pneumonia was higher in the deceased group than in the 1st group (p < 0.001).Conclusion. Risk factors associated with mortality include manifestations of MM such as anaemia, thrombocytopenia, renal dysfunction and late diagnosis at stage III of the disease. Chronic heart failure, as a complication of cardiovascular disease, is a risk factor for adverse outcome. Comorbidity, infectious diseases (pneumonia) are associated with a worse prognosis, probably due to poorer tolerability of standard therapy.
- 16 June 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
Open AccessRisk factors associated with mortality in patients with multiple myeloma
Introduction. According to foreign authors some laboratory markers and comorbidity are independent predictors of death in multiple myeloma (MM).Aim. To identify risk factors associated with mortality in patients with MM.Materials and methods. A retrospective analysis of 149 medical records of patients of the hematology department of the Regional Clinical Hospital with a diagnosis of multiple myeloma was carried out. The patients are divided into two groups depending on the clinical outcome: the 1st group includes 90 living patients; the 2nd group includes 59 patients whose death occurred in the hospital during the period from 2010–2019. Of the 149 patients: 87 women (58%), 62 men (42%). The mean age of the patients was 65.7 ± 8.7 years. The clinical, demographic and laboratory indicators of the groups were analyzed, and comorbidity was assessed using the Charlson index.Results. In the 1st group of patients, there were 35 men (39%) and 55 women (61%). The ratio of men to women is 1:1.6. The mean age in this group is 67 ± 9.1 years. The 2nd group is represented by 27 (46%) men, 32 (54%) women. The mean age was 63.7 ± 7.6 years. In the 1st group of patients, all patients were diagnosed with stage III disease, with most patients in the subgroup associated with renal dysfunction (p = 0.002). Anaemia and markers of renal damage were more frequent in the group of deceased patients (p < 0.001, p = 0.002, respectively). Comparative analysis of laboratory indicators showed that in the haemogram of the group of living patients, the level of erythrocytes, haemoglobin, platelets was significantly higher than in group 2 (p < 0.05); the level of creatinine, urea was 1.8 times higher in the group of deceased patients than in the group of living patients (p < 0.05). Chronic heart failure was statistically significantly more common in the deceased group than in the living group (22% vs. 7.8%, p = 0.025). The incidence of pneumonia was higher in the deceased group than in the 1st group (p < 0.001).Conclusion. Risk factors associated with mortality include manifestations of MM such as anaemia, thrombocytopenia, renal dysfunction and late diagnosis at stage III of the disease. Chronic heart failure, as a complication of cardiovascular disease, is a risk factor for adverse outcome. Comorbidity, infectious diseases (pneumonia) are associated with a worse prognosis, probably due to poorer tolerability of standard therapy.
- Open Access
- 24 May 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 6,p. 301-308
Difficulties in diagnosing the causes of stroke and myocardial infarction in young people: A clinical case study
Recently, the number of myocardial infarctions and strokes in young patients has been increasing. Most often these are non-atherogenic causes: congenital heart defects, coagulopathies, arteritis, etc. To discuss the difficulties of diagnosing the causes of strokes and myocardial infarctions in young patients, we present a clinical case of a 39-year-old patient with atrial septal defect and genetic thrombophilia, which resulted in myocardial infarction and embolic stroke. A special feature of this clinical case can be considered the fact of the development of embolic myocardial infarction during pregnancy in a patient with atrial septal defect surgery in childhood. However, the study on thrombophilia was not complete after a miscarriage during the first pregnancy. Suspicions of the formation of a right-left shunt were confirmed upon hospitalization due to embolic myocardial infarction. After cesarean delivery, endovascular occlusion of the atrial septal defect with an occluder was performed, and 4 years after the installation of the occluder, the patient developed an embolic stroke, as evidenced by the multiplicity of ischemic foci of the brain during imaging studies. Examination for thrombophilia after a repeated ischemic event revealed homozygous mutations in factor VII (A/A), FGB (A/A), heterozygous mutations in folate cycle genes (C/T polymorphism in the MTHFR gene, A/G polymorphism in the MTR gene), heterozygous polymorphism in the PAI-1 gene (4G/5G). The hematologist recommended constant anticoagulant therapy rivaroxaban at a dose of 2.5 mg 2 times a day. The described clinical case demonstrates the polyethology and complexity of the pathogenetic mechanisms of myocardial infarction and stroke in a young patient. If these events occur in young people, it is important to perform echocardiography (with a bubble test, if necessary), daily monitoring of electrocardiography, and laboratory examination for thrombophilia.
- 24 May 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 6,p. 301-308
Open AccessDifficulties in diagnosing the causes of stroke and myocardial infarction in young people: A clinical case study
Recently, the number of myocardial infarctions and strokes in young patients has been increasing. Most often these are non-atherogenic causes: congenital heart defects, coagulopathies, arteritis, etc. To discuss the difficulties of diagnosing the causes of strokes and myocardial infarctions in young patients, we present a clinical case of a 39-year-old patient with atrial septal defect and genetic thrombophilia, which resulted in myocardial infarction and embolic stroke. A special feature of this clinical case can be considered the fact of the development of embolic myocardial infarction during pregnancy in a patient with atrial septal defect surgery in childhood. However, the study on thrombophilia was not complete after a miscarriage during the first pregnancy. Suspicions of the formation of a right-left shunt were confirmed upon hospitalization due to embolic myocardial infarction. After cesarean delivery, endovascular occlusion of the atrial septal defect with an occluder was performed, and 4 years after the installation of the occluder, the patient developed an embolic stroke, as evidenced by the multiplicity of ischemic foci of the brain during imaging studies. Examination for thrombophilia after a repeated ischemic event revealed homozygous mutations in factor VII (A/A), FGB (A/A), heterozygous mutations in folate cycle genes (C/T polymorphism in the MTHFR gene, A/G polymorphism in the MTR gene), heterozygous polymorphism in the PAI-1 gene (4G/5G). The hematologist recommended constant anticoagulant therapy rivaroxaban at a dose of 2.5 mg 2 times a day. The described clinical case demonstrates the polyethology and complexity of the pathogenetic mechanisms of myocardial infarction and stroke in a young patient. If these events occur in young people, it is important to perform echocardiography (with a bubble test, if necessary), daily monitoring of electrocardiography, and laboratory examination for thrombophilia.
- 31 December 2024
- Published by Ryazan State Medical University in Nauka Molodykh (Eruditio Juvenium)
- Vol. 12 (4)
Analysis of the Interrelation between Clinical, Laboratory and Radiological Characteristics of Patients with COVID-19 Depending on the Outcome
INTRODUCTION: The clinical picture of COVID-19 has been highly variable since the onset of the pandemic: most patients present with mild symptoms, while others develop severe respiratory failure. It seems relevant to compare subjective and objective manifestations of COVID-19 in hospitalized patients and to evaluate the prognostic significance of clinical, laboratory and radiological characteristics of COVID-19. AIM: To analyze the interrelation between the evidence of subjective and objective data, comorbidity in patients with COVID-19 depending on the outcome of the disease. MATERIALS AND METHODS: The study included 96 patients aged from 25 to 95 years, hospitalized in COVID hospital of City Clinical Emergency Care Hospital of Ryazan from February to May 2022. Patients underwent evaluation of cough and dyspnea intensity on Borg scale, physical examination, laboratory examination, X-ray computed tomography (X-ray CT) of lungs or roentgenography. Depending of the clinical outcome, patients were divided into 2 groups: a group of survivors (68 patients) and a group of deceased (28 patients). Statistical analysis of the data was performed using Statistica 10.0 software package (Stat Soft Inc., USA). RESULTS: The most common complaints on admission were shortness of breath (75%) and general weakness (96.8%). Twenty-four patients indicated absence of dyspnea, while in 19 of them, saturation below 95.0% was recorded. In patients with ‘silent’ dyspnea, X-ray CT revealed statistically significant strong reverse correlation relationships between saturation and lung lesion volume (р < 0.05). Deceased patients had higher subjective evidence of dyspnea and frequency of distant wheezes (р = 0.002 and р < 0.0001, respectively). Overweight, postinfarction cardiosclerosis, chronic heart failure, type 2 diabetes mellitus were more common among deceased patients. Saturation on admission was statistically significantly lower in the group of deceased (р < 0.0001). The first degree of lung damage on X-ray CT was more common in the group of survivors (0.009), the fourth degree of lung damage more commonly occurred in the group of deceased (р = 0.01). In the group of deceased, the hemoglobin level was significantly lower (р = 0,044), and the levels of fibrinogen, lactate dehydrogenase (LDH), urea, glucose, were significantly higher than in the group of survivors. CONCLUSION: When evaluating the severity of the disease in patients with COVID-19, it is necessary to take into account not only the level of laboratory markers, such as LDH, fibrinogen, urea, fasting glycemia, laboratory instrumental test results that evaluate the severity of respiratory failure and spread of the lung tissue damage, but also subjective manifestations of the disease such as higher intensity of dyspnea and distant wheezes. Patients who have reduced saturation with no complaints of dyspnea require increased attention.
- 31 December 2024
- Published by Ryazan State Medical University in Nauka Molodykh (Eruditio Juvenium)
- Vol. 12 (4)
Analysis of the Interrelation between Clinical, Laboratory and Radiological Characteristics of Patients with COVID-19 Depending on the Outcome
INTRODUCTION: The clinical picture of COVID-19 has been highly variable since the onset of the pandemic: most patients present with mild symptoms, while others develop severe respiratory failure. It seems relevant to compare subjective and objective manifestations of COVID-19 in hospitalized patients and to evaluate the prognostic significance of clinical, laboratory and radiological characteristics of COVID-19. AIM: To analyze the interrelation between the evidence of subjective and objective data, comorbidity in patients with COVID-19 depending on the outcome of the disease. MATERIALS AND METHODS: The study included 96 patients aged from 25 to 95 years, hospitalized in COVID hospital of City Clinical Emergency Care Hospital of Ryazan from February to May 2022. Patients underwent evaluation of cough and dyspnea intensity on Borg scale, physical examination, laboratory examination, X-ray computed tomography (X-ray CT) of lungs or roentgenography. Depending of the clinical outcome, patients were divided into 2 groups: a group of survivors (68 patients) and a group of deceased (28 patients). Statistical analysis of the data was performed using Statistica 10.0 software package (Stat Soft Inc., USA). RESULTS: The most common complaints on admission were shortness of breath (75%) and general weakness (96.8%). Twenty-four patients indicated absence of dyspnea, while in 19 of them, saturation below 95.0% was recorded. In patients with ‘silent’ dyspnea, X-ray CT revealed statistically significant strong reverse correlation relationships between saturation and lung lesion volume (р < 0.05). Deceased patients had higher subjective evidence of dyspnea and frequency of distant wheezes (р = 0.002 and р < 0.0001, respectively). Overweight, postinfarction cardiosclerosis, chronic heart failure, type 2 diabetes mellitus were more common among deceased patients. Saturation on admission was statistically significantly lower in the group of deceased (р < 0.0001). The first degree of lung damage on X-ray CT was more common in the group of survivors (0.009), the fourth degree of lung damage more commonly occurred in the group of deceased (р = 0.01). In the group of deceased, the hemoglobin level was significantly lower (р = 0,044), and the levels of fibrinogen, lactate dehydrogenase (LDH), urea, glucose, were significantly higher than in the group of survivors. CONCLUSION: When evaluating the severity of the disease in patients with COVID-19, it is necessary to take into account not only the level of laboratory markers, such as LDH, fibrinogen, urea, fasting glycemia, laboratory instrumental test results that evaluate the severity of respiratory failure and spread of the lung tissue damage, but also subjective manifestations of the disease such as higher intensity of dyspnea and distant wheezes. Patients who have reduced saturation with no complaints of dyspnea require increased attention.
- 27 December 2024
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 32 (4) , 627-636
Clinical masks of primary cardiac tumors: a clinical case report
INTRODUCTION: Primary cardiac tumors are rare, 75% of them are benign, half of which are myxomas. Despite histological benignity, untimely diagnosed myxoma can have serious complications. Myxoma is characterized by non-specific symptoms, however, a typical triad of atrial myxoma symptoms is distinguished: (1) symptoms of mitral valve obstruction manifested by heart failure and weakness, (2) symptoms of embolism and (3) systemic manifestations. AIM: Illustration of the variety of clinical manifestations, discussion of diagnostic difficulties, formation of clinical alertness in the observation of left atrial myxoma. MATERIALS AND METHODS: Left atrial myxoma in a 49-year-old male patient debuted at the age of 44 with the development of a transient cerebrovascular disorder in the right carotid system manifested by dysarthria and paresis of the facial muscles; at that time, no echocardiographic (EchoCG) examination was conducted. Several years later, the clinical presentation of heart failure manifested: shortness of breath when walking, edema of lower limbs. EchoCG revealed a sizable mass in the left atrium 33 mm × 55 mm fixed to the interatrial septum, prolapsing into the left ventricle and partially stenosing the left atrioventricular opening. Dilation of both atria, of the right ventricle, pronounced pulmonary hypertension, 2-degree regurgitation on the tricuspid valve, 2-degree regurgitation on the pulmonic valve, hydropericardium and hydrothorax on the right were found. The clinical case was also characterized by the developed bilateral thrombosis of the superficial femoral vein with signs of flotation. The development of venous thrombosis in a patient with cardiac myxoma can probably be considered as a systemic manifestation of the tumor disease. After compensation for the heart failure and implantation of a cava filter, the tumor was surgically removed, the morphological picture corresponded to cardiac myxoma with hemorrhages of various ages. CONCLUSION: The case demonstrates the need for performing EchoCG in a transient ischemic attack, in ischemic stroke, to screen for intracardiac masses capable of frustrating cerebral circulation by cardioembolic mechanism, especially at a young age in the absence of other cardiovascular risk factors. The clinical picture consistently showed all the symptoms of the classic triad of cardiac myxoma: embolic syndrome, symptoms of mitral valve obstruction and systemic manifestations. The prognosis for patients with cardiac myxoma depends on the severity of thromboembolic syndrome and severity of heart failure. Timely diagnosis and surgical removal of cardiac myxoma provide a favorable prognosis.
- 27 December 2024
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 32 (4) , 627-636
Clinical masks of primary cardiac tumors: a clinical case report
INTRODUCTION: Primary cardiac tumors are rare, 75% of them are benign, half of which are myxomas. Despite histological benignity, untimely diagnosed myxoma can have serious complications. Myxoma is characterized by non-specific symptoms, however, a typical triad of atrial myxoma symptoms is distinguished: (1) symptoms of mitral valve obstruction manifested by heart failure and weakness, (2) symptoms of embolism and (3) systemic manifestations. AIM: Illustration of the variety of clinical manifestations, discussion of diagnostic difficulties, formation of clinical alertness in the observation of left atrial myxoma. MATERIALS AND METHODS: Left atrial myxoma in a 49-year-old male patient debuted at the age of 44 with the development of a transient cerebrovascular disorder in the right carotid system manifested by dysarthria and paresis of the facial muscles; at that time, no echocardiographic (EchoCG) examination was conducted. Several years later, the clinical presentation of heart failure manifested: shortness of breath when walking, edema of lower limbs. EchoCG revealed a sizable mass in the left atrium 33 mm × 55 mm fixed to the interatrial septum, prolapsing into the left ventricle and partially stenosing the left atrioventricular opening. Dilation of both atria, of the right ventricle, pronounced pulmonary hypertension, 2-degree regurgitation on the tricuspid valve, 2-degree regurgitation on the pulmonic valve, hydropericardium and hydrothorax on the right were found. The clinical case was also characterized by the developed bilateral thrombosis of the superficial femoral vein with signs of flotation. The development of venous thrombosis in a patient with cardiac myxoma can probably be considered as a systemic manifestation of the tumor disease. After compensation for the heart failure and implantation of a cava filter, the tumor was surgically removed, the morphological picture corresponded to cardiac myxoma with hemorrhages of various ages. CONCLUSION: The case demonstrates the need for performing EchoCG in a transient ischemic attack, in ischemic stroke, to screen for intracardiac masses capable of frustrating cerebral circulation by cardioembolic mechanism, especially at a young age in the absence of other cardiovascular risk factors. The clinical picture consistently showed all the symptoms of the classic triad of cardiac myxoma: embolic syndrome, symptoms of mitral valve obstruction and systemic manifestations. The prognosis for patients with cardiac myxoma depends on the severity of thromboembolic syndrome and severity of heart failure. Timely diagnosis and surgical removal of cardiac myxoma provide a favorable prognosis.
- 31 December 2023
- Published by Ryazan State Medical University in Nauka Molodykh (Eruditio Juvenium)
Peculiarities of Exudative Pericarditis in Cardiac Metastasis
INTRODUCTION: Exudative pericarditis in a cancer patient is often a first manifestation of the disease and is considered a marker of a poor prognosis. According to the literature, the neoplastic etiology of a first-diagnosed exudative pericarditis is indicated by the following signs: cardiac tamponade, recurrent pericarditis, fever above 38°С, subacute course of pericarditis, absence of the effect of nonsteroidal anti-inflammatory drugs. The article presents a case report of cardiac metastasis in renal carcinoma manifested by acute exudative pericarditis in a 63-year old female patient. CONCLUSION: Diagnosis and treatment of cardiac metastasis presents difficulties in clinical practice due to the rarity of the disease, scarce symptoms, and the absence of clear recommendations for the management of such patients. Nevertheless, this rare route of metastasizing can significantly influence patient treatment and prognosis and requires cooperation between different specialists of the multidisciplinary team: oncologists, cardiologists, urologists (in case of renal cell carcinoma).
- 31 December 2023
- Published by Ryazan State Medical University in Nauka Molodykh (Eruditio Juvenium)
Peculiarities of Exudative Pericarditis in Cardiac Metastasis
INTRODUCTION: Exudative pericarditis in a cancer patient is often a first manifestation of the disease and is considered a marker of a poor prognosis. According to the literature, the neoplastic etiology of a first-diagnosed exudative pericarditis is indicated by the following signs: cardiac tamponade, recurrent pericarditis, fever above 38°С, subacute course of pericarditis, absence of the effect of nonsteroidal anti-inflammatory drugs. The article presents a case report of cardiac metastasis in renal carcinoma manifested by acute exudative pericarditis in a 63-year old female patient. CONCLUSION: Diagnosis and treatment of cardiac metastasis presents difficulties in clinical practice due to the rarity of the disease, scarce symptoms, and the absence of clear recommendations for the management of such patients. Nevertheless, this rare route of metastasizing can significantly influence patient treatment and prognosis and requires cooperation between different specialists of the multidisciplinary team: oncologists, cardiologists, urologists (in case of renal cell carcinoma).
- Open Access
- 16 July 2023
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 31 (2) , 221-230
Prognostic Significance of Cardiac Fat Deposits in Patients with Coronary Heart Disease
INTRODUCTION: Obesity is one of the leading risk factors for the development of cardiovascular diseases. At present, of the greatest scientific interest are local deposits of adipose tissue as a possible morphological substrate for the development of this group of diseases. Along with the traditional risk factors, one more risk factor for a poor prognosis of cardiovascular disease can be a change in the thickness of the epicardial fat (EF) and of the interatrial septum (IAS) in case of its lipomatosis. AIM: To study the significance of EF and of IAS thickness as markers of cardiovascular risk in coronary heart disease. MATERIALS AND METHODS: The study involved 116 individuals with coronary heart disease (55 men (47%) and 61 women (53%), mean age 68 [61; 72] years). Thickness of EF and IAS was evaluated by the method of echocardiography. The frequency of poor outcomes was evaluated using KaplanMeier method, ROC-curve analysis. The differences were considered statistically significant at p 0.05. RESULTS: In the group of patients with unstable angina, the threshold value of IAS thickness was 0.7 cm (p 0.001), and of EF thickness 0.8 cm (2 = 10.89, p = 0.001), in the group of patients with myocardial infarction 0.7 cm (p 0.001) and 0.8 cm (p 0.001), respectively. In the group of patient with unstable angina, IAS thickness 0.7 cm (2 = 10.3, p = 0.0013) and EF thickness 0.8 cm (2 = 10.89, p = 0.001) demonstrate a poor prognosis in comparison with the parameters below the threshold values. In the group of patients with myocardial infarction, IAS thickness 0.7 cm (2 = 8.4, p = 0.005) and EF 0.8 cm (2 = 9.66, p = 0.0019) demonstrate poor prognosis in comparison with the parameters below the threshold values. CONCLUSION: In unstable angina and myocardial infarction, the value of IAS thickness 0.7 cm (p = 0.0013 and p = 0.005, respectively) and of EF thickness 0.8 cm (p = 0.001 and p = 0.0019, respectively) present a poor prognosis compared to lower values. It is recommended that EF and IAS thickness be determined in echocardiography as an additional marker for a poor prognosis in coronary heart disease.
- 16 July 2023
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 31 (2) , 221-230
Open AccessPrognostic Significance of Cardiac Fat Deposits in Patients with Coronary Heart Disease
INTRODUCTION: Obesity is one of the leading risk factors for the development of cardiovascular diseases. At present, of the greatest scientific interest are local deposits of adipose tissue as a possible morphological substrate for the development of this group of diseases. Along with the traditional risk factors, one more risk factor for a poor prognosis of cardiovascular disease can be a change in the thickness of the epicardial fat (EF) and of the interatrial septum (IAS) in case of its lipomatosis. AIM: To study the significance of EF and of IAS thickness as markers of cardiovascular risk in coronary heart disease. MATERIALS AND METHODS: The study involved 116 individuals with coronary heart disease (55 men (47%) and 61 women (53%), mean age 68 [61; 72] years). Thickness of EF and IAS was evaluated by the method of echocardiography. The frequency of poor outcomes was evaluated using KaplanMeier method, ROC-curve analysis. The differences were considered statistically significant at p 0.05. RESULTS: In the group of patients with unstable angina, the threshold value of IAS thickness was 0.7 cm (p 0.001), and of EF thickness 0.8 cm (2 = 10.89, p = 0.001), in the group of patients with myocardial infarction 0.7 cm (p 0.001) and 0.8 cm (p 0.001), respectively. In the group of patient with unstable angina, IAS thickness 0.7 cm (2 = 10.3, p = 0.0013) and EF thickness 0.8 cm (2 = 10.89, p = 0.001) demonstrate a poor prognosis in comparison with the parameters below the threshold values. In the group of patients with myocardial infarction, IAS thickness 0.7 cm (2 = 8.4, p = 0.005) and EF 0.8 cm (2 = 9.66, p = 0.0019) demonstrate poor prognosis in comparison with the parameters below the threshold values. CONCLUSION: In unstable angina and myocardial infarction, the value of IAS thickness 0.7 cm (p = 0.0013 and p = 0.005, respectively) and of EF thickness 0.8 cm (p = 0.001 and p = 0.0019, respectively) present a poor prognosis compared to lower values. It is recommended that EF and IAS thickness be determined in echocardiography as an additional marker for a poor prognosis in coronary heart disease.